Evaluating T-cell resilience can help researchers predict—and possibly improve—the outcomes of cancer immunotherapy.
May 2022. Full story at National Cancer Institute.
Evaluating T-cell resilience can help researchers predict—and possibly improve—the outcomes of cancer immunotherapy.
May 2022. Full story at National Cancer Institute.